Showing results (1831-1840 of 2,046) with videos related to

Sort By:
Pageof 205
American Heart Journal|April 24, 2012
Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohortHarvey D White, Harmony R Reynolds, Antonio C Carvalho, et al.
European Heart Journal|November 26, 2008
Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery TrialVenu Menon, Camille A Pearte, Christopher E Buller, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 17, 2019
The Hyperpolarization-Activated HCN4 Channel is Important for Proper Maintenance of Oscillatory Activity in the Thalamocortical SystemMehrnoush Zobeiri, Rahul Chaudhary, Anne Blaich, et al.
Diseases of the Colon and Rectum|September 25, 2021
Slow and Steady Wins the Race: A Solid Case for a 3-Stage Approach in Ulcerative ColitisMichael C Plietz, Maia Kayal, Anam Rizvi, et al.
Journal of Cardiac Failure|February 28, 2021
Dynamic Assessment of Pulmonary Artery Pulsatility Index Provides Incremental Risk Assessment for Early Right Ventricular Failure After Left Ventricular Assist DeviceMatthew H Gonzalez, Qiuqing Wang, Dmitry M Yaranov, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 28, 2020
Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door-to-balloon timeChetan P Huded, Samir R Kapadia, Jad A Ballout, et al.
Clinical Cardiology|August 25, 2020
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)Calvin C Sheng, Debasis Sahoo, Siddharth Dugar, et al.
Journal of Clinical Microbiology|June 9, 2004
Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of IndiaNagadenahalli B Siddappa, Prashanta K Dash, Anita Mahadevan, et al.
Annals of Neurology|June 3, 2004
Functional brain changes in presymptomatic Huntington's diseaseSarah A J Reading, Adam C Dziorny, Laura A Peroutka, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2018
Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin releaseKerstin Göbel, Chloi-Magdalini Asaridou, Monika Merker, et al.
Pageof 205